<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39524261</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2250-0685</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of orthopaedic case reports</Title><ISOAbbreviation>J Orthop Case Rep</ISOAbbreviation></Journal><ArticleTitle>Transient Osteoporosis of Hip as a Part of "Long COVID-19": A Case Series.</ArticleTitle><Pagination><StartPage>220</StartPage><EndPage>224</EndPage><MedlinePgn>220-224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.13107/jocr.2024.v14.i11.4974</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Transient osteoporosis of the hip (TOH) presents with symptoms such as groin pain, discomfort, and the presence of bone edema detected on magnetic resonance imaging (MRI) scans. We have observed an increase in the occurrence of TOH in patients following the COVID-19 pandemic.</AbstractText><AbstractText Label="CASE REPORT" NlmCategory="UNASSIGNED">In this series, we present four cases of TOH that developed after COVID-19 infection. The average cumulative dose of prednisolone exposure in these cases was 788 mg (range 300-1050 mg). The mean duration between diagnosis and COVID-19 infection was 102 days (range 90-123 days). The average duration from the resolution of symptoms to the initiation of bisphosphonate therapy was 98 days (range 90-120 days).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Bisphosphonate therapy appears to be an effective pharmacological treatment for TOH, providing rapid pain relief and shortening the disease's natural course. This study demonstrates positive outcomes, including normalized MRI results and no progression to avascular necrosis, suggesting bisphosphonates as a promising management option for TOH patients.</AbstractText><CopyrightInformation>Copyright: &#xa9; Indian Orthopaedic Research Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Agarwala</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, P D Hinduja Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim (West), Mumbai, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijayvargiya</LastName><ForeName>Mayank</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, P D Hinduja Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim (West), Mumbai, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Upadhyay</LastName><ForeName>Avinashdev</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, P D Hinduja Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim (West), Mumbai, Maharashtra, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Orthop Case Rep</MedlineTA><NlmUniqueID>101641392</NlmUniqueID><ISSNLinking>2250-0685</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Transient osteoporosis of hip</Keyword><Keyword MajorTopicYN="N">bisphosphonates</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword></KeywordList><CoiStatement>Conflict of Interest: Nil</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>11</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39524261</ArticleId><ArticleId IdType="pmc">PMC11546001</ArticleId><ArticleId IdType="doi">10.13107/jocr.2024.v14.i11.4974</ArticleId><ArticleId IdType="pii">JOCR-14-220</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1163&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwala SR, Vijayvargiya M, Pandey P. Avascular necrosis as a part of &#x2018;long COVID - 19&#x2019;. BMJ Case Rep. 2021;14:e242101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256728</ArticleId><ArticleId IdType="pubmed">34215639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaffi J, Vanni E, Facchini G, Miceli M, Ursini F. Transient osteoporosis of the hip: A novel vascular manifestation of COVID-19? Rheumatology (Oxford) 2023;62:e127&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494465</ArticleId><ArticleId IdType="pubmed">36124962</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisi N, Patoulias D, Tsagkaris C, Tsagatakis M, Goules D. Transient hip osteoporosis: Etiopathogenetic, clinical, and imaging approach. Mediterr J Rheumatol. 2022;33:196&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9450209</ArticleId><ArticleId IdType="pubmed">36128206</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwala S, Vijayvargiya M. Single dose therapy of zoledronic acid for the treatment of transient osteoporosis of hip. Ann Rehabil Med. 2019;43:314&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6637057</ArticleId><ArticleId IdType="pubmed">31311253</ArticleId></ArticleIdList></Reference><Reference><Citation>Arayssi TK, Tawbi HA, Usta IM, Hourani MH. Calcitonin in the treatment of transient osteoporosis of the hip. Semin Arthritis Rheum. 2003;32:388&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">12833247</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizer R, Meraner D, Meizer E, Radda C, Landsiedl F, Aigner N. Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost. Indian J Orthop. 2009;43:36&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739485</ArticleId><ArticleId IdType="pubmed">19753177</ArticleId></ArticleIdList></Reference><Reference><Citation>Emad Y, Ragab Y, El-Shaarawy N, Rasker JJ. Transient osteoporosis of the hip, complete resolution after treatment with alendronate as observed by MRI description of eight cases and review of the literature. Clin Rheumatol. 2012;31:1641&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22933125</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy EF. The pathology of transient regional osteoporosis. Iowa Orthop J. 1998;18:35&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2378158</ArticleId><ArticleId IdType="pubmed">9807706</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: Follow-up to eight years. J Bone Joint Surg Br. 2009;91:1013&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19651826</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>